Paperback
Unveiling pharma’s value, profits, and challenges: a must-read for industry leaders.

Pharma and Profits

Balancing Innovation, Medicine, and Drug Prices

$45.60

  • Paperback

    112 pages

  • Release Date

    17 June 2022

Check Delivery Options

Summary

High-level commentary on various facets of the pharmaceutical industry from a key leader in the field

This book clearly explains the value that the pharmaceutical industry offers to society, which is often underreported against the more negative topic of high drug prices. It also offers an overview for drug discovery and development professionals, highlighting the challenges that such drug hunters should be aware of when developing new drugs. Case studies to illustrat…

Book Details

ISBN-13:9781119881339
ISBN-10:1119881331
Author:John L. LaMattina
Publisher:John Wiley & Sons Inc
Imprint:John Wiley & Sons Inc
Format:Paperback
Number of Pages:112
Release Date:17 June 2022
Weight:136g
Dimensions:8mm x 150mm x 226mm
A-Format
B-Format
Pharma and Profits by John L. LaMattina - ISBN: 9781119881339
150 × 226 mm
C-Format
A4
mm / in
About The Author

John L. LaMattina

John LaMattina, PhD is the former Senior Vice President, Pfizer Inc and President, Pfizer Global Research and Development. In this role, Dr. LaMattina oversaw the drug discovery and development efforts of over 12,000 colleagues in the United States, Europe and Asia. Currently a Senior Partner with PureTech Health, he is the author of Drug Truths: Dispelling the Myths About Pharma R&D (2008) and Devalued and Distrusted – Can the pharmaceutical industry restore its broken image? (2013), both published by Wiley.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.